News

Health and Me on MSN1d
FDA Mandates ADHD Drug Labels To Warn Of Weight Loss Risk
The FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...
Merck's Hypertension Drug On FDA Fast Track For Label Expansion
Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.
Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
pharmaphorum3d
PDURS explained: The FDA’s new framework for adding software to drug labels - pharmaphorum
In this fireside chat webinar, experts break down the FDA's new PDURS framework for adding software to drug labels. Learn how it impacts pharma and what you need to know. Join us on Tuesday 9th ...
pharmaphorum2d
The rise of prescription drug abuse and drug diversion
As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Ben Hargreaves speaks to an expert in the area to learn how ...
FDA to revise labeling of ADHD medication to indicate weight loss risk
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
Pacific Daily News4d
Lujan introduces legislation to exempt prescription drugs from BPT
Bill 220-37 is “An Act to Add a New § 26203 (f) To Article 2, Chapter 26, Title 11 Guam Code Annotated, Relative to Expanding the Business Privilege Tax Exemptions List to Include Prescription ...
AARP3d
Medicare Drug Price Negotiations Start Sept. 1
The tens of millions of beneficiaries who get their prescription drugs through Medicare will have an opportunity this fall to let federal officials know the importance and impact of the first 10 ...